{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:13:25Z","timestamp":1781201605459,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":35,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013465","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.coph.2023.102394","type":"journal-article","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T00:41:49Z","timestamp":1689468109000},"page":"102394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle"],"prefix":"10.1016","volume":"71","author":[{"given":"Caterina","family":"Marchioretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Andreotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Zuccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8634-0767","authenticated-orcid":false,"given":"Maria","family":"Pennuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2023.102394_sref1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"La Spada","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.coph.2023.102394_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/brain\/awm289","article-title":"CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA","volume":"131","author":"Suzuki","year":"2008","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.coph.2023.102394_sref3","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1212\/WNL.0000000000000507","article-title":"Correlation of clinical and molecular features in spinal bulbar muscular atrophy","volume":"82","author":"Fratta","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.coph.2023.102394_bib4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/mus.25977","article-title":"Correlation between the CAG repeat size and electrophysiological findings in patients with spinal and bulbar muscular atrophy","volume":"57","author":"Kim","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.coph.2023.102394_bib5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.18.7.671","article-title":"Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait","volume":"18","author":"Kennedy","year":"1968","journal-title":"Neurology"},{"key":"10.1016\/j.coph.2023.102394_sref6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/jnnp-2015-311305","article-title":"Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients","volume":"87","author":"Querin","year":"2016","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.coph.2023.102394_bib7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/jnnp-2017-316961","article-title":"Beyond motor neurons: expanding the clinical spectrum in Kennedy's disease","volume":"89","author":"Manzano","year":"2018","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.coph.2023.102394_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nmd.2021.11.007","article-title":"Kennedy disease in two sisters with biallelic CAG expansions of the androgen receptor gene","volume":"32","author":"M\u00fcller","year":"2022","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.coph.2023.102394_bib9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1212\/WNL.59.5.770","article-title":"Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women","volume":"59","author":"Schmidt","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.coph.2023.102394_bib10","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1172\/JCI28773.","article-title":"Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model","volume":"116","author":"Yu","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2023.102394_bib11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","article-title":"Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"35","author":"Katsuno","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.coph.2023.102394_sref12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nm878","article-title":"Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"9","author":"Katsuno","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2023.102394_bib13","first-page":"1211","article-title":"Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials","volume":"266","author":"Hashizume","year":"2019","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.coph.2023.102394_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(10)70321-5","article-title":"Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial","volume":"10","author":"Fern\u00e1ndez-Rhodes","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coph.2023.102394_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(10)70182-4","article-title":"Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"9","author":"Katsuno","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coph.2023.102394_bib16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ana.21540","article-title":"Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy","volume":"65","author":"Banno","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coph.2023.102394_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mce.2017.07.005","article-title":"From gene to therapy in spinal and bulbar muscular atrophy: are we there yet?","volume":"465","author":"Pennuto","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.coph.2023.102394_bib18","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/jnnp-2020-322949","article-title":"Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA)","volume":"91","author":"Hashizume","year":"2020","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.coph.2023.102394_sref19","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.neuron.2010.08.034","article-title":"Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy","volume":"67","author":"Nedelsky","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.coph.2023.102394_sref20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41467-023-36186-9","article-title":"LSD1\/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice","volume":"14","author":"Prakasam","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2023.102394_sref21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nm.4500","article-title":"Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy","volume":"24","author":"Badders","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2023.102394_sref22","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41467-023-36185-w","article-title":"Defective excitation-contraction coupling and mitochondrial respiration precede mitochondrial Ca2+ accumulation in spinobulbar muscular atrophy skeletal muscle","volume":"14","author":"Marchioretti","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2023.102394_bib23","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/hmg\/11.17.1967","article-title":"Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor","volume":"11","author":"Lieberman","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coph.2023.102394_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00401-016-1550-4","article-title":"Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet","volume":"132","author":"Rocchi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.coph.2023.102394_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012922","article-title":"Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease\/spinal bulbar muscular atrophy","volume":"5","author":"Mo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2023.102394_bib26","first-page":"3873","article-title":"Androgen insensitivity syndrome","volume":"22","author":"Gul\u00eda","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.coph.2023.102394_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.coph.2023.102394_bib28","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.0474-22","article-title":"Two elderly men with myasthenia gravis during androgen deprivation therapy for prostate cancer","author":"Kanazawa","year":"2023","journal-title":"Intern Med Tokyo Jpn"},{"key":"10.1016\/j.coph.2023.102394_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/iju5.12465","article-title":"Editorial Comment to Castration-resistant prostate cancer diagnosed during leuprorelin treatment for spinal and bulbar muscular atrophy","volume":"5","author":"Pennuto","year":"2022","journal-title":"IJU Case Rep"},{"key":"10.1016\/j.coph.2023.102394_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/iju5.12447","article-title":"Castration-resistant prostate cancer diagnosed during leuprorelin treatment for spinal and bulbar muscular atrophy","volume":"5","author":"Yanase","year":"2022","journal-title":"IJU Case Rep"},{"key":"10.1016\/j.coph.2023.102394_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.celrep.2016.08.084","article-title":"Rescue of metabolic alterations in AR113Q skeletal muscle by peripheral androgen receptor gene silencing","volume":"17","author":"Giorgetti","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.coph.2023.102394_bib32","article-title":"Bicalutamide and trehalose ameliorate spinal and bulbar muscular atrophy pathology in mice","author":"Galbiati","year":"2023","journal-title":"Neurother J Am Soc Exp Neurother"},{"key":"10.1016\/j.coph.2023.102394_bib33","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.celrep.2014.02.008","article-title":"Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy","volume":"7","author":"Lieberman","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.coph.2023.102394_bib34","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1172\/JCI99042","article-title":"Androgen receptor polyglutamine expansion drives age-dependent quality control defects and muscle dysfunction","volume":"128","author":"Nath","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2023.102394_sref35","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/hmg\/ddw073","article-title":"A\u00a0small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy","volume":"25","author":"Bott","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coph.2023.102394_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18357","article-title":"The aspartyl protease DDI2 activates Nrf1 to compensate for proteasome dysfunction","volume":"5","author":"Koizumi","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.coph.2023.102394_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/JCI134565","article-title":"Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy","volume":"131","author":"Pluciennik","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2023.102394_bib38","first-page":"140","article-title":"Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases","volume":"21","author":"Sacheck","year":"2007","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"10.1016\/j.coph.2023.102394_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00401-020-02156-4","article-title":"MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease","volume":"140","author":"Nath","year":"2020","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.coph.2023.102394_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12397","article-title":"MRF4 negatively regulates adult skeletal muscle growth by repressing MEF2 activity","volume":"7","author":"Moretti","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2023.102394_bib41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00401-022-02428-1","article-title":"AR cooperates with SMAD4 to maintain skeletal muscle homeostasis","volume":"143","author":"Forouhan","year":"2022","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.coph.2023.102394_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1212\/01.wnl.0000341274.61236.02","article-title":"Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease)","volume":"72","author":"Preisler","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.coph.2023.102394_bib43","first-page":"1693","article-title":"High-intensity training in patients with spinal and bulbar muscular atrophy","volume":"266","author":"Heje","year":"2019","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.coph.2023.102394_bib44","first-page":"2513","article-title":"Safety and tolerability of strength training in spinal and bulbar muscular atrophy: a case report","volume":"5","author":"Shieh","year":"2022","journal-title":"J\u00a0Rehabil Med Clin Commun"},{"key":"10.1016\/j.coph.2023.102394_bib45","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1113\/JP279208","article-title":"Muscle BDNF improves synaptic and contractile muscle strength in Kennedy's disease mice in a muscle-type specific manner","volume":"598","author":"Halievski","year":"2020","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.coph.2023.102394_bib46","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/hmg\/ddm109","article-title":"Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity","volume":"16","author":"Palazzolo","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coph.2023.102394_bib47","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuron.2009.07.019","article-title":"Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy","volume":"63","author":"Palazzolo","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.coph.2023.102394_bib48","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2119\/molmed.2012.00271","article-title":"Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy","volume":"18","author":"Rinaldi","year":"2012","journal-title":"Mol Med Camb Mass"},{"key":"10.1016\/j.coph.2023.102394_bib49","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1474-4422(18)30320-X","article-title":"Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial","volume":"17","author":"Grunseich","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.coph.2023.102394_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/srep41046","article-title":"Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes","volume":"7","author":"Milioto","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2023.102394_bib51","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1212\/WNL.0b013e318295d766","article-title":"Pilot trial of clenbuterol in spinal and bulbar muscular atrophy","volume":"80","author":"Querin","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.coph.2023.102394_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf9526","article-title":"Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy","volume":"8","author":"Polanco","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coph.2023.102394_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade1694","article-title":"Antagonistic effect of cyclin-dependent kinases and a calcium-dependent phosphatase on polyglutamine-expanded androgen receptor toxic gain of function","volume":"9","author":"Piol","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.coph.2023.102394_bib54","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1038\/s41598-019-41240-y","article-title":"Muscle contractility in spinobulbar muscular atrophy","volume":"9","author":"Dahlqvist","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2023.102394_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/genes13010109","article-title":"Nucleic acid-based therapeutic approach for spinal and bulbar muscular atrophy and related neurological disorders","volume":"13","author":"Hirunagi","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.coph.2023.102394_bib56","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1093\/hmg\/ddv300","article-title":"Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy","volume":"24","author":"Sahashi","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coph.2023.102394_bib57","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/mt.2016.13","article-title":"MiR-298 counteracts mutant androgen receptor toxicity in spinal and bulbar muscular atrophy","volume":"24","author":"Pourshafie","year":"2016","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"10.1016\/j.coph.2023.102394_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi6896","article-title":"Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity","volume":"7","author":"Lim","year":"2021","journal-title":"Sci Adv"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489223000498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489223000498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:57:39Z","timestamp":1761461859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489223000498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":58,"alternative-id":["S1471489223000498"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2023.102394","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2023.102394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102394"}}